Barriers to Adherence with Immunosuppressive Therapy in Patients with Uveitis
Barriers to IMT treatment include laboratory study cost, difficulty with medication administration, and adhering to medication schedules. Monthly cost of medication was high for some, but no patients were unable to take IMT due to insurance loss. Addressing these barriers may improve IMT adherence for uveitis patients and better clinical outcomes.
Authors
- Rayna Marshall (ORCID: https://orcid.org/0000-0002-6961-1278)
- Karen R. Armbrust (ORCID: https://orcid.org/0000-0001-9381-4756)
- Laura J. Kopplin
- Cynthia L. Montana (ORCID: https://orcid.org/0000-0003-3524-2352)
- Eric L. Crowell (ORCID: https://orcid.org/0000-0002-6986-5307)
- Meghan Berkenstock (ORCID: https://orcid.org/0000-0001-7517-7706)
- A. Taylor
- Karen Sun
- Michael Frankland
Institutions
- University of Minnesota (US)
- University of Wisconsin–Madison (US)
- Johns Hopkins University (US)
- Georgetown University (US)
- Washington University in St. Louis (US)
- University of Minnesota System (US)
- Minneapolis VA Health Care System (US)
- Drexel University (US)
- The University of Texas at Austin (US)
- Georgetown College (US)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1080/09273948.2024.2430709
- Citations
- 3
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.02